Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Adult ADHD News

News
Microdosing Associated With Increased Mindfulness, Lower Neuroticism in ADHD Patients
11/28/2023
Tom Valentino, Digital Managing Editor
A study conducted by researchers in the Netherlands has found that microdosing psychedelics for 4 weeks induced an increase in mindfulness and a decrease in neuroticism among adults diagnosed with attention-deficit/hyperactivity disorder...
A study conducted by researchers in the Netherlands has found that microdosing psychedelics for 4 weeks induced an increase in mindfulness and a decrease in neuroticism among adults diagnosed with attention-deficit/hyperactivity disorder...
A study conducted by researchers...
11/28/2023
Psych Congress Network

Advertisement

Slight Symptom Gains but More Dropouts With Unlicensed Stimulant Doses in ADHD
News
Slight Symptom Gains but More Dropouts With Unlicensed Stimulant Doses in ADHD
11/09/2023
Jolynn Tumolo
In adults with ADHD, stimulant doses escalated beyond FDA recommendations were associated with small, and perhaps nonclinically meaningful, additional improvements in ADHD symptoms.
In adults with ADHD, stimulant doses escalated beyond FDA recommendations were associated with small, and perhaps nonclinically meaningful, additional improvements in ADHD symptoms.
In adults with ADHD, stimulant...
11/09/2023
Psych Congress Network
Adult ADHD Linked With Increased Motor Vehicle Crash Risk
News
Adult ADHD Linked With Increased Motor Vehicle Crash Risk
11/01/2023
Evi Arthur
ADHD was associated with an increased crash risk in older adult drivers compared to drivers without ADHD, according to a study published in JAMA Network Open.
ADHD was associated with an increased crash risk in older adult drivers compared to drivers without ADHD, according to a study published in JAMA Network Open.
ADHD was associated with an...
11/01/2023
Psych Congress Network
stock medication
News
Pilot Study Finds Solriamfetol Beneficial for Adults With ADHD
10/19/2023
Jolynn Tumolo
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug...
10/19/2023
Psych Congress Network

Advertisement

News
UK Study Spots Link Between Tech Addictions and ADHD Traits
10/13/2023
Tom Valentino, Digital Managing Editor
A new study by researchers at Bournemouth University shows a link between various forms of technology addiction and traits of attention-deficit/hyperactivity disorder (ADHD), even among adults who have not been diagnosed with ADHD.
A new study by researchers at Bournemouth University shows a link between various forms of technology addiction and traits of attention-deficit/hyperactivity disorder (ADHD), even among adults who have not been diagnosed with ADHD.
A new study by researchers at...
10/13/2023
Addiction Professional
ADHD Causally Linked With Several Psychiatric Disorders
News
ADHD Causally Linked With Several Psychiatric Disorders
10/10/2023
Jolynn Tumolo
Attention-deficit/hyperactivity disorder (ADHD) is an independent risk factor for major depressive disorder (MDD), post-traumatic stress disorder (PTSD), anorexia nervosa, and suicide attempt, according to a study published online in BMJ...
Attention-deficit/hyperactivity disorder (ADHD) is an independent risk factor for major depressive disorder (MDD), post-traumatic stress disorder (PTSD), anorexia nervosa, and suicide attempt, according to a study published online in BMJ...
Attention-deficit/hyperactivity...
10/10/2023
Psych Congress Network
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
News
Brain Training Aids Overall Cognitive Ability in Adults With ADHD
10/02/2023
Jolynn Tumolo
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training interventions may offer a small benefit for overall cognitive outcomes in adults with attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published in...
Computerized cognitive training...
10/02/2023
Psych Congress Network

Advertisement

Brain Fitness Program Improves Symptoms in Patients With ADHD, PCS, Memory Loss
News
Brain Fitness Program Improves Symptoms in Patients With ADHD, PCS, Memory Loss
09/25/2023
Jolynn Tumolo
A 12-week “brain fitness” program significantly improved neurocognitive measures as well as anxiety, sleep, and other symptoms in patients with attention-deficit/hyperactivity disorder (ADHD).
A 12-week “brain fitness” program significantly improved neurocognitive measures as well as anxiety, sleep, and other symptoms in patients with attention-deficit/hyperactivity disorder (ADHD).
A 12-week “brain fitness”...
09/25/2023
Psych Congress Network
Financial Incentive Appears to Increase Engagement Among Adult ADHD App Users
News
Financial Incentive Appears to Increase Engagement Among Adult ADHD App Users
08/23/2023
Jolynn Tumolo
A financial incentive for using an app designed for adults with attention-deficit/hyperactivity disorder (ADHD) resulted in a 100% adoption rate of the FOCUS ADHD app, according to a study published online in European Psychiatry.
A financial incentive for using an app designed for adults with attention-deficit/hyperactivity disorder (ADHD) resulted in a 100% adoption rate of the FOCUS ADHD app, according to a study published online in European Psychiatry.
A financial incentive for using...
08/23/2023
Psych Congress Network
App Plus Incentive Promising for ADHD Medication Adherence
News
App Plus Incentive Promising for ADHD Medication Adherence
08/14/2023
Evi Arthur
Use of an attention-deficit/hyperactivity disorder (ADHD) focus app had a high adoption rate in adults with ADHD, though it had no effect on treatment adherence without an incentive, according to a randomized clinical trial published in...
Use of an attention-deficit/hyperactivity disorder (ADHD) focus app had a high adoption rate in adults with ADHD, though it had no effect on treatment adherence without an incentive, according to a randomized clinical trial published in...
Use of an...
08/14/2023
Psych Congress Network

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use